TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 316 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $33,391,605 | -19.9% | 2,125,500 | -15.9% | 0.10% | -23.3% |
| Q1 2023 | $41,674,575 | -4.0% | 2,528,797 | -9.1% | 0.13% | -12.8% |
| Q4 2022 | $43,410,120 | +103.9% | 2,782,700 | +114.1% | 0.15% | +57.4% |
| Q3 2021 | $21,292,000 | -8.1% | 1,299,900 | -5.6% | 0.09% | -9.6% |
| Q2 2021 | $23,175,000 | +95.5% | 1,377,000 | +111.4% | 0.10% | +79.3% |
| Q4 2020 | $11,854,000 | +157.6% | 651,300 | +143.4% | 0.06% | +107.1% |
| Q3 2019 | $4,602,000 | -76.9% | 267,562 | -72.6% | 0.03% | -68.9% |
| Q1 2019 | $19,892,000 | – | 976,514 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |